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Summary
Zygotic genome activation (ZGA) is a major genome pro-
gramming event whereby the cells of the embryo begin to
adopt specified fates. Experiments in Drosophila and zebra-
fish have revealed that ZGAdepends on transcription factors
that provide large-scale control of gene expression by direct
and specific binding to gene regulatory sequences [1–5].
Zelda (Zld) plays such a role in theDrosophila embryo,where
it has been shown to control the action of patterning signals
[1, 2]; however, the mechanisms underlying this effect
remain largely unclear. A recent model proposed that Zld
binding sites act as quantitative regulators of the spatiotem-
poral expression of genes activated by Dorsal (Dl), the
morphogen that patterns the dorsoventral axis [6]. Here we
tested thismodel experimentally, using enhancers of brinker
(brk) and short gastrulation (sog), both of which are directly
activated by Dl, but at different concentration thresholds
[7–9]. In agreement with the model, we show that there is a
clear positive correlation between the number of Zld binding
sites and the spatial domain of enhancer activity. Likewise,
the timing of expression could be advanced or delayed. We
present evidence that Zld facilitates binding of Dl to regula-
tory DNA, and that this is associated with increased chro-
matin accessibility. Importantly, the change in chromatin
accessibility is strongly correlated with the change in Zld
binding, but not Dl. We propose that the ability of genome
activators to facilitate readout of transcriptional input is
key to widespread transcriptional induction during ZGA.Results and Discussion
In blastoderm embryos, brinker (brk) is activated in an eight- to
ten-cell-wide domain that develops into the ventral neurogenic
ectoderm (NE), whereas short gastrulation (sog) is expressed
in a broader band of 16–18 cells encompassing the entire NE
(see Figures 1A and 1I). Both genes have the same ventral
expression boundary due to repression by Snail (Sna) in the
presumptive mesoderm [11–15]. The dorsal borders of their
domains lie in regions of the Dorsal (Dl) gradient where
amounts are low and change little, raising the question of
how their enhancers can interpret small differences in Dl
concentrations.
sog and brk each have two reported cis-regulatory modules
(enhancers) that are active in early embryos [10, 16–20]. The3Co-first author
*Correspondence: chris.rushlow@nyu.edusog intronic lateral stripe enhancer (LSE) [16] is less well
conserved and drives a slightly narrower stripe of expression
relative to the sog shadow enhancer [17], also known as the
neurogenic ectoderm enhancer (NEE), which recapitulates
the broad endogenous sog pattern [18]. The brk 50 and 30
enhancers both support lateral stripes similar to endogenous
brk [10, 17]; however, the brk 30 enhancer drives a more
dynamic pattern that broadens at cellularization [19]. Thus,
we focused on the brk 50 enhancer to avoid confounding
dynamic change of width.
The sog 426 bp NEE contains three CAGGTAG heptamer
sites for optimal Zelda (Zld) binding. However, the brk
498 bp 50 enhancer does not have any canonical Zld binding
sites (also known as TAGteam sites [21]). To explain its Zld
dependence, we used electrophoretic mobility shift assays
to look for Zld binding sites in the brk 50 enhancer. We identi-
fied three CAGGTCA sequences and a tandem GAGGCAC
AGGCAC sequence that promote very weak Zld binding,
which was abolished upon mutation of the sites (see Figure S1
available online).
To test whether altering the number of Zld binding sites in
the NE enhancers can affect the expression they drive, we
created mutant forms of the brk and sog enhancers. The sog
NEE (sog wt, Figure 1C) drives a lacZ reporter expression
pattern identical to endogenous sog (Figure 1A). Mutation of
all three CAGGTAG sites dramatically reduced the expression
width (sog 0; Figures 1E and 1R). Similar changes were also
observed by Liberman et al. (2009) when they mutated the
CAGGTAG sites in the sog LSE [20]. Costaining of lacZ and
endogenous sog illustrates that the narrowed lacZ domain re-
sulted from a collapse of the dorsal, not the ventral, border
(data not shown). We infer that without Zld, sog is unable to
be activated by the lower levels of Dl in the dorsal neuroecto-
derm region. In embryos lacking maternal Zld [1] (referred to
herein as zld2), both the endogenous sog and sog wt domains
shrink and become sporadic (Figures 1B and 1D). This is not
due to an indirect effect on the Dl concentration gradient
because it is unchanged in zld2 (Figure S2). Thus, loss of Zld
in trans, or Zld binding sites in cis, has the same effect on
NEE activity, indicating a direct modulation of sog by Zld.
Next we performed the opposite experiment by introducing
three CAGGTAG sites into the brk 50 enhancer. This modified
enhancer (brk +3a) drives a considerably expanded expres-
sion domain (Figure 1M) compared to brk wt (Figures 1K and
1R). A second form of the brk enhancer with CAGGTAG sites
added to different locations (brk +3b) also drives the same
expanded expression domain (Figure S3), arguing against
the requirement of precise motif grammar in Zld’s regulation
of NE genes.
To rule out the possibility that the expansion in domainwidth
of brk +3a is caused by inadvertent disruption of a repressor
binding site rather than addition of Zld binding sites, we
mutated the three added CAGGTAG sequences in brk +3a
into 7-mers that are neither the original sequence nor Zld
binding sites (Figure 1O; brk +3m). Mutation of these sites
reduced the expanded domain of brk +3a back to a width
similar to brk wt (Figure 1R). When each of the brk +3a,
brk +3b, and brk +3m transgenic enhancers was placed into
a zld2 background, narrow and sporadic expression resulted
Figure 1. The Number of Zld Binding Sites Determines the Spatial Extent of Dl Target Gene Expression
Wild-type (A, C, E, G, H, I, K, M, O, and P) and zld2 (B, D, F, J, L, and N) embryos in nuclear cycle (nc) 14 were hybridizedwith RNA probes synthesized against
cDNA sequences for sog (A and B), brk (I and J), or lacZ (C–H and K–P) for transgenic embryos. Here and in subsequent figures, embryos are oriented
anterior to the left and dorsal up. A schematic representation of the enhancer that drives lacZ expression is shown below transgenic embryos (C–H and
K–P). Green triangle, Dl site; dark purple diamond, canonical Zld site; light purple diamond, noncanonical Zld site; red diamond, mutagenized Zld site.
(C–F) Mutation of all three Zld sites in the sog NEE caused a reduction in the expression domain it drives.
(G and H) Elimination of one (H) or two (G) Zld sites in sog NEE resulted in a stepwise narrowing of the expression domain.
(K–N) Addition of three Zld sites to the brk 50 enhancer led to a Zld-dependent expansion in expression.
(O) Mutation of the three added Zld sites yielded an expression similar to that driven by the brk wt enhancer.
(P) Removal of all Zld sites in the brk 50 enhancer led to sporadic and thin expression pattern. Anterior-posterior modulation seems to be in play for the
expression of brk, which could be explained by the presence of two Bicoid (Bcd) sites in this enhancer [10].
(Q) Scatterplot showing thewidth of expression domain (in the number of cells it spans) driven by different forms of the sogNEE that contain zero (0TAG), one
(1TAG), two (2TAG), or three (3TAG) Zld sites. Each dot represents the average from at least 20 embryos. The width of expression domain correlates with
number of Zld sites (linear regression R2 = 0.66).
(R) Bar chart showing the width of expression domain driven by the brk wt, brk +3a, brk +3m, sog 0, and sog wt enhancers. Data are represented as mean6
SEM. ***p < 0.005, t test.
See also Figures S1–S3.
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1342resembling that of endogenous brk in zld2 (Figures 1J and 1N;
data not shown), again supporting that the CAGGTAG-driven
broadened expression is Zld dependent. Moreover, mutation
of the newly found weak Zld binding sites led to a narrowed
and weakened stripe of expression, identical to the pattern
of brk wt in zld2 (Figures 1L and 1P).
To better correlate the number of Zld sites with the extent of
reporter expression, we constructed six different forms of thesog NEE containing either one or two of the three CAGGTAG
sites (see Figure 1G for a one-site line [sog A] and Figure 1H
for a two-site line [sog AB]). The width of expression correlated
moderately to the number of Zld sites in the enhancer (Fig-
ure 1Q; R2 = 0.66). However, some sites appear to be more
important than others in contributing to the expression width,
indicating a context dependency for Zld binding sites. From
our results and others’ work demonstrating weakened NE
Figure 2. The Number of Zld Binding Sites Deter-
mines the Timing of Dl Target Gene Activation
nc 11 (A, C, E, and G) and nc 12 (B, D, F, and H)
embryos carrying sog (A–D) or brk (E–H)
transgenes were hybridized with RNA probes
synthesized against intronic sequences of the
yellow reporter gene. Dl antibody staining (not
shown) was used to orient embryos. DAPI-
stained nuclei expressing yellow reporter gene
are pseudocolored in yellow. Compared to the
sog wt enhancer (A and B), mutation of all Zld
sites in the sogNEE (sog 0; C and D) results in de-
layed and sporadic expression.
(E–H) Embryos carrying the brk enhancer with
added Zld sites (brk +3a; G andH) have advanced
initiation of transcription compared to embryos
carrying the brk wt enhancer (brk wt; E and F).
(I) Table showing the number of embryos carrying
the four transgenic lines that display any expres-
sion from nc 9 to nc 12.
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23], it is evident that Zld is indispensable for the proper expres-
sion of NE genes.
We next asked whether the number of Zld binding sites also
influences the timing of Dl target expression, since previous
reports have implicated Zld as a developmental timer. Harri-
son et al. (2011) observed a correlation between the onset of
zygotic gene expression and strength of Zld binding at nc 8
[3]. Besides that, when the enhancer region of zen, which con-
tains four Zld binding sites, was multimerized, it drove preco-
cious activation of reporter expression [21]. And finally, Nien
et al. (2011) showed that the expression of many patterning
genes is delayed in zld2 embryos [2], including sog and brk.
We reasoned that since Dl nuclear concentrations increase
from nc 10 to nc 14 [24–26], the lower levels of Dl present in
earlier cycles would no longer be adequate to activate target
genes without Zld’s input, resulting in delayed activation of
sog and brk [6, 27].
To measure the onset of transcription, we determined when
the four transgenic enhancers (sog wt, sog 0, brk wt, and
brk +3a) could activate an intron-containing yellow reporter
gene [28], which allows us to detect nascent transcripts.
Reporter expression driven by the sog wt enhancer was first
detectable in nc 10 embryos, whereas no reporter activity
was observed for the sog 0 enhancer until nc 11 (Figure 2I;
see false color of fluorescence in situ hybridization signal).
Even in nc 12, the expression driven by sog 0 is more sporadiccompared to sog wt (Figures 2A–2D).
Unlike in nc 14 embryos, reporter
expression can be seen in ventral nuclei
of nc 11 and nc 12 embryos because the
Sna repressor has not yet accumulated
to high levels [15]. Adding three Zld
sites to the brk enhancer resulted in
advanced initiation of reporter activity
from nc 11 to nc 10 (Figure 2I), and
reporter expression also became more
robust, in terms of both the proportion
of nuclei showing expression and the
ratio of embryos with expressing nuclei
(Figures 2E–2I). Our results clearly illus-
trate that by manipulating Zld binding
sites, the timing of NE gene activationcan be altered. Temporal regulation by transcription factor
binding sites has also been shown in Ciona where the number
of Brachyury binding sites governs the timing of notochord
gene expression [29].
We believe that Zld regulates the temporal and spatial
expression of NE genes by promoting Dl activity, rather than
acting independently, because nuclear Dl is absolutely
required for the activation of brk and sog, which exhibit no
expression in genetic backgrounds lacking nuclear Dl [20,
30]. One possible mechanism may involve cooperativity at
the level of DNA binding [6]. To test the hypothesis that the
extent of Zld binding impacts Dl binding at target enhancers,
we performed chromatin immunoprecipitation followed by
quantitative PCR (ChIP-qPCR) to measure Zld and Dl binding
to the different transgenic enhancers.
The sog 0 enhancer without Zld sites has diminished Zld
binding when compared to sog wt (t test, p = 0.004; Figure 3A).
Dl binding is also much reduced (p = 0.002; Figure 3B). As an
internal control, Zld and Dl binding to the endogenous sog
locus showed no significant difference between the lines (p =
0.464 and 0.288, respectively; Figures 3A and 3B). On the other
hand, introduction of Zld sites into thebrk transgenic enhancer
led to higher Zld binding (p = 0.0047; Figure 3D) and Dl binding
(p = 0.004; Figure 3E), while Zld and Dl binding to the endoge-
nous locus remained similar between lines (p = 0.221 and
0.452, respectively; Figures 3D and 3E). These results illustrate
that changing the number of Zld sites, and therefore changing
Figure 3. Zld Promotes Dl Binding to Target Enhancers and Increases Chromatin Accessibility
Bar charts showing Zld (A, D, and G) and Dl (B, E, and H) ChIP-qPCR results and DNase I digestion-qPCR results (C, F, and I) performed on 1.5–3 hr embryos
carrying transgenic enhancers. Error bars indicate SEM from three biological replicates. *p < 0.05; **p < 0.01; ***p < 0.005.
(A–C) Embryos carrying the sog enhancer with mutated Zld sites (sog 0) have reduced Zld (A) and Dl (B) binding, as well as lower sensitivity to DNase I diges-
tion (C), on the reporter region compared to embryos carrying the sog wt enhancer.
(D–F) The brk transgenic enhancer with added Zld sites (brk +3a) has higher Zld (D) and Dl (E) binding and higher sensitivity to DNase I digestion (F) than the
brk wt enhancer.
(G–I) The brk transgenic enhancer with mutated Dl sites (brk 0Dl) has reduced Zld (G) and Dl (H) binding and slightly lower sensitivity to DNase I digestion (I)
than the brk wt enhancer. Shown are ChIP enrichment or DNase I hypersensitivity relative to an unrelated genomic region (see Experimental Procedures).
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level of Dl binding to its target sites in vivo.
Our results from reporter expression analyses and ChIP
experiments suggest that Zld promotes transcriptional output
by facilitating Dl DNA binding. Zld might directly interact with
Dl, leading to cooperative DNA binding as in the Dl-Twist
(Twi) interaction [14, 31–33]. Alternatively, Zld might assist
factor binding by interacting with common coactivators or by
changing the local chromatin accessibility [34, 35]. We favor
the latter possibility for several reasons: (1) Zld binding greatly
overlaps with that of many other transcription factors such as
Bcd, Hunchback, Dl, Twi, Sna, andMothers against Dpp (Mad)
[2]; (2) Zld helps the binding of Twi and Bcd to target DNA
[23, 36]; (3) the presence of Zld binding sites is associated
with high levels of transcription factor binding [37]; and (4)
the Zld site (CAGGTA; [2]) is the most enriched motif in tran-
scription factor binding ‘‘HOT regions,’’ which were seen to
correlate with decreased nucleosome density [37–39]. Hence,
it is more likely that Zld plays a more general role, such as
‘‘opening’’ the underlying chromatin, than that it interacts spe-
cifically with multiple other factors.
We therefore went on to address the hypothesis that Zld
facilitates the binding of Dl by making the local chromatin
more accessible. DNase I’s preferential digestion of nucleo-
some-depleted DNA in the genome can be used to map active
regulatory regions accessible for transcription factor binding
[40, 41]. We performed DNase I hypersensitivity assays fol-
lowed by qPCR (DNase I-qPCR) to measure the chromatin‘‘openness’’ of transgenic enhancers carrying varying
numbers of Zld sites. The sog transgenic enhancer region
had significant reduction of chromatin accessibility when Zld
sites were mutated (w1.6-fold, p = 0.002; Figure 3C), while
adding Zld sites to the brk transgenic enhancer increased
sensitivity to DNase I digestion (w1.6-fold, p = 0.002; Fig-
ure 3F). The DNase I hypersensitivity assessed on endogenous
brk and sog loci were comparable between transgenic lines
(p = 0.118 and 0.114, respectively; Figures 3C and 3F), serving
as a control for embryo staging between transgenic lines and
the DNase I digestion procedure.
These results suggest that the presence of Zld sites, and
thus Zld binding, makes the local chromatin more accessible
for Dl, and potentially other transcription factors. However, it
is feasible that the total number of factor binding sites influ-
ences chromatin accessibility rather than the number of Zld
sites in particular. Therefore, we assayed the DNase I hyper-
sensitivity of a transgenic brk enhancer that lacks all Dl binding
sites and shows no reporter expression (brk 0Dl; Figure S3). Dl
binding decreased nearly to background levels (w2.3-fold, p =
0.001; Figure 3H) compared to brk wt, but the Zld binding and
DNase I hypersensitivity showed only slight decreases (w1.5-
fold, p = 0.012 andw1.2-fold, p = 0.0002, respectively; Figures
3G and 3I), which is not comparable to the effects seen upon
manipulation of Zld sites on the brk and sog enhancers (Fig-
ures 3A–3F). We reason that the binding of each transcription
factor may contribute to the DNase I hypersensitivity to a
certain extent but that the major influence comes from Zld
Figure 4. The Change in Chromatin Accessibility Correlates with the
Change in Zld Binding on Target Enhancers
Zld and Dl ChIP enrichment and DNase I hypersensitivity on the transgenic
region were normalized to the endogenous enhancer locus, and the fold
change was then calculated for the two lines under comparison (sog
0 versus sog wt, brk +3a versus brk wt, and brk 0Dl versus brk wt). Blue
dots and green dots represent Zld and Dl, respectively. The change in Zld
binding between lines strongly correlates with the change in DNase I hyper-
sensitivity (linear regression R2 = 0.98), whereas the change in Dl binding
does not (R2 = 0.02).
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sites to chromatin accessibility, we calculated the fold change
in Zld and Dl binding for sog 0, brk +3a, and brk 0Dl relative to
their corresponding wt transgenic enhancers and then corre-
lated the fold change in factor binding with the change in
DNase I hypersensitivity (Figure 4). We found a strong correla-
tion between the change in Zld binding and DNase I hypersen-
sitivity (R2 = 0.98), whereas the change in Dl binding andDNase
I hypersensitivity do not correlate (R2 = 0.02). These results
support the idea that the number of Zld sites rather than Dl
sites is important in determining chromatin accessibility.
Using Zld’s coregulation of NE genes as a case in point, we
have shed light on how Zld functions as a zygotic genome acti-
vator. Our data reveal that Zld works in combination with Dl
and regulates Dl target genes by binding differentially to their
regulatory sequences. Changing the number of Zld sites on
Dl target gene enhancers has a pronounced effect on their
expression both temporally and spatially. As a uniformly
distributed factor, Zld supplies positional information by pro-
moting Dl binding to target enhancers, thereby increasing
the ‘‘apparent dosage’’ of Dl. Zld’s input is especially impor-
tant where the level of morphogen is low and likely plays a
similar role for other key factors in the blastoderm embryo,
such as Twi, Bcd, and Mad. Uniform factors have been found
to act in combination with Sonic Hedgehog in neural tube dif-
ferentiation [42], and our findings on how Zld potentiates
morphogen activity will be relevant to vertebrate systems.
Although our results do not rule out other possible mecha-
nisms, they strongly support the idea that Zld binding in-
creases chromatin accessibility, which we believe contributes
greatly to how it activates such a wide range of targets. In this
model, the amount of Zld binding on a region would determine
how open and therefore how active it is. At the center of this
property is Zld’s ability to occupy a large fraction of its recog-
nition sites in early embryos [3]. Besides that, Zld is present in
nuclei as early as nc 2 [2], which is considerably earlier than
other factors (e.g., Bcd, nc 6; Dl, nc 10) [25, 26, 43]. Therefore,
Zldmay act as a pioneer factor as previously suggested [3, 27],but whether Zld binds to its sites in nucleosomes and reposi-
tions them, or whether it recruits histone modifiers that in
turn affect binding of other factors like Dl, awaits further inves-
tigation. Interestingly, this idea may extend beyond flies, since
newly discovered genome activators in zebrafish zygotic
genome activation have been seen to cooperate with develop-
mental regulators and prime the genome for subsequent
activation [4, 5]. Thus, it seems that developmental control of
zygotic genome activation is highly similar in flies and fish.
Experimental Procedures
Transgenic Reporter Analysis
Mutant forms of the 426 bp sog NEE and the 498 bp brk 50 enhancer were
created via site-specific mutagenesis or by direct synthesis using Inte-
grated DNA Technologies custom gene synthesis service. Enhancer and
primer sequences can be found in Supplemental Experimental Procedures.
In situ hybridization and antibody staining were performed as described
previously [1, 44].
Zld and Dl ChIP-qPCR
ChIPwas performed on 1.5–3 hr embryos using amodified protocol from the
Zeitlinger lab [45]. Three biological replicates were performed for each ChIP
experiment. Three primer sets (see Supplemental Experimental Procedures
for primer sequences) were used to probe the reporter locus (targetOut), the
endogenous enhancer (targetEn), and an unrelated genomic region on chr2L
(control), respectively. ChIP enrichment was then calculated as (ChIPtarget/
ChIPcontrol)/(inputtarget/inputcontrol) for both reporter and endogenous loci.
DNase I Digestion-qPCR
DNase I digestion was performed on 1.5–3 hr embryos as described previ-
ously [41], with some modifications. Three biological replicates were per-
formed for each DNase I digestion experiment. The same primer sets as
in the ChIP-qPCR experiments were used. We first calculated the percent
remaining DNA at target loci relative to the control region, which did not
showDNase I hypersensitivity [41], and then normalized the percent remain-
ing DNA after 15 min digestion to that without DNase I digestion, giving rise
to normalized percent remaining DNA ([target15min/control15min]/[target0min/
control0min]). DNase I hypersensitivity was finally presented as 1/(normal-
ized percent remaining DNA) for both reporter and endogenous loci.
Supplemental Information
Supplemental Information includes three figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.cub.2014.04.032.
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